卡帕阿片类受体的激活通过在血膜上隔离STAT3来抑制创伤后关节炎
Haixia Liu1, Renhuan Huang1, Ziang Zhuo1
1Department of Stomatology, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Cell communication and signaling : CCS
|June 18, 2024
概括
卡帕阿片类受体 (KOR) 的激活可通过阻止细胞中STAT3信号传递来缓解骨关节炎疼痛和软骨损伤. 这种机制涉及KOR在血上与STAT3结合,抑制驱动OA进展的免疫反应.
科学领域:
- 生物医学科学 生物医学科学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨关节炎 (OA) 涉及关节炎症和软骨退化.
- 卡帕阿片类受体 (KOR) 信号传导在OA病变发生过程中发挥作用.
- 在OA中KOR的精确分子机制尚不清楚.
研究的目的:
- 为了研究由KOR激活触发的下游分子事件.
- 阐明KOR信号在OA病理中的作用.
- 确定OA的潜在治疗点.
主要方法:
- 在中介半月体 (DMM) 鼠标模型OA的不稳定性中,对KOR激动剂 (U50,488H) 的关节内注射.
- 行为 (热板测试) 和组织学 (红色固体绿色染色) 评估.
- 基因和蛋白质表达的分析使用RNA-seq,RT-qPCR,免疫组织化学和西方涂抹.
- 接近标签,质谱,共免疫沉 (Co-IP) 和免疫光 (IF) 来识别与 KOR 相互作用的蛋白质.
主要成果:
- 在DMM小鼠中,KOR激活减少了OA诱导的疼痛和软骨退化.
- 在TNF-α刺激的冠状细胞中,KOR激活逆转了MMPs,IL-6,IL-1β和酸化STAT3.3的上调.
- KOR激活通过在血膜上与STAT3结合来抑制STAT3的核转位,近距离标记和Co-IP证实了这一点.
结论:
- 在OA中,KOR激活提供了对软骨损伤的保护.
- 这种保护作用是通过将STAT3隔离在血上来实现的.
- 这种机制使STAT3依赖的免疫反应失活,从而导致OA的发病.
相关概念视频
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
GPCR Desensitization
5.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
5.9K
Analgesia and Pain Management
575
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
575
Opioid Receptors: Overview
714
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
714
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
Amplifying Signals via Enzymatic Cascade
8.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K


